Takeaways Perianesthesia and sterile processing leaders are feeling the pain of staffing shortages. Strategies to recruit and retain staff include raising pay, establishing clinical ladders, training programs, and a positive work environment. A 2022 study found that Certified Post Anesthesia nurses are more satisfied with their jobs than noncertified nurses.…

Read More

Editor's Note The Food and Drug Administration (FDA), on April 19, identified the recall by Fresenius Kabi USA of its Ivenix Infusion System as Class I, the most serious. The recall was initiated because of a leak in the system that allows fluid to enter the administration set loading area…

Read More

Editor's Note The Food and Drug Administration (FDA), on April 13, updated prescribing information for all opioid pain medications, including requiring all packaging to have updated labeling and safety information. This includes stating that: for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medications, the risk of overdose…

Read More

Editor's Note The Food and Drug Administration (FDA), on April 12, issued a Safety Communication recommending that consumers, healthcare providers, and facilities not use certain surgical N95 respirators and to use caution with certain surgical masks and pediatric face masks, all manufactured by O&M Halyard. The FDA says it is…

Read More

Editor's Note In this study, led by the University of Alabama at Birmingham, overlapping surgery was shown to reduce in-hospital mortality and to have similar patient safety indicators and readmission rates as nonoverlapping cases. Operative time was shown to increase with overlapping cases. A total of 87,426 cases were included…

Read More

Editor's Note The Food and Drug Administration, on April 7, identified the recall by Philips Respironics of certain reworked DreamStation continuous positive airway pressure (CPAP) and bileveled positive airway pressure (BiPAP) machines as Class I, the most serious. These machines also were recalled in June 2021. The recall was initiated…

Read More

Editor's Note The Joint Commission, on April 4, released its Sentinel Event Data 2022 Annual Review, which covered serious adverse events from January 1 through December 31, 2022. There were 1,441 sentinel events reported in 2022, a 19% increase over 2021, and a 78% increase over 2020, with COVID-19 continuing…

Read More

Editor's Note The World Health Organization on March 30 reported that although there is an overall downward trend in COVID-19 cases and deaths, 21 countries are reporting increases in cases of Omicron subvariant XBB.1.16, particularly India. XBB.1.16 has a similar profile to XBB.1.5, which is the dominant strain in the…

Read More

Editor's Note The American Society of Anesthesiologists (ASA), on March 29, issued a news report urging the public to learn to recognize and respond to an opioid overdose, now that the Food and Drug Administration has approved naloxone for sale over the counter. Naloxone, which is commonly sold as a…

Read More

Editor's Note The Joint Commission, on March 22, announced that it is seeking comments on proposed new requirements to address environmental sustainability for the hospital and critical access hospital programs. The aim of the proposed new Leadership (LD) Standard LD.05.01.01 is to help facilities minimize their carbon footprints as they…

Read More